Will Apixaban Change Practice in Atrial Fibrillation?

The oral anticoagulant apixaban was recently approved in Europe for the prevention of stroke and systemic embolism in adults with nonvalvular atrial fibrillation. What role will this agent play?

Source: Medscape Cardiology Podcast - January 9, 2013 Category: Cardiology Authors: Medscape Source Type: podcasts